01/21/2015 - 11:50am

With specialty and biotech drugs claiming an ever-greater share of the pharmaceutical market and spawning a backlash from payers and patients over their high price tags, pharmacy operators are smack in the middle of a growing tug of war between the drug industry, the public and private health plans struggling to keep up with the new drug-cost paradigm.

01/21/2015 - 11:46am

With the development and use of innovative wearable health devices and smartphone health apps exploding, the decentralization of health care will likely reach a crescendo in 2015. Increasingly, consumers and physicians are embracing technologies that can continuously monitor a host of such physical conditions as heartbeat, lipid levels, medication adherence or motion — and wirelessly transmit the data to a host computer or smartphone. 

01/21/2015 - 11:26am

Boehringer Ingelheim Pharmaceuticals on Wednesday announced that its Spiriva Respimat (tiotropium bromide) inhalation spray is now available by prescription through pharmacies across the United States. 

 

01/21/2015 - 11:07am

Drug Channels Institute on Tuesday offered a sneak peek to its 2014-15 Economic Report on Retail, Mail and Specialty Pharmacies with a look at the largest pharmacies, ranked by total U.S. prescription dispensing revenues for calendar year 2014.

01/20/2015 - 5:00pm

The Generic Pharmaceutical Association announced Tuesday that Ralph Neas, president and CEO, would be stepping down from his position in the fall of 2015.

01/20/2015 - 4:32pm

Walgreens on Tuesday announced that it has signed a definitive agreement with Madison Dearborn Partners, a leading private equity firm based in Chicago, under which MDP will acquire a majority interest in Walgreens Infusion Services. 

01/20/2015 - 3:56pm

Partner up or risk being left behind. That’s the choice facing more and more pharmacy groups grappling with accountable care, outcomes-based reimbursement and risk-sharing collaborative health networks. 

 

01/20/2015 - 11:44am

Teva Pharmaceutical on Tuesday announced the U.S. Supreme Court’s decision in Teva Pharmaceuticals USA vs. Sandoz et al. that reversed the Federal Circuit Court’s judgment of invalidity of Teva’s ‘808 patent for Copaxone (glatiramer acetate injection) 20 mg/mL.

01/20/2015 - 11:25am

Flu incidence has spread from the central United States and picked up across the West between Jan. 12 and Jan. 19.